Actively Recruiting
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
Led by Seoul National University Hospital · Updated on 2024-11-07
340
Participants Needed
9
Research Sites
101 weeks
Total Duration
On this page
Sponsors
S
Seoul National University Hospital
Lead Sponsor
S
Seoul National University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to generate clinical evidence and assess the feasibility of a shared decision-making (SDM) model for the selection of Tolvaptan in patients with ADPKD.
CONDITIONS
Official Title
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants between the age of 18 to 80
- Diagnosed with chronic kidney disease stage 2 or 3
- Diagnosed with autosomal dominant polycystic kidney disease classified as 1C, 1D, or 1E by Mayo classification
- Able to communicate and use digital devices
- No severe visual impairment or cognitive dysfunction
You will not qualify if you...
- Previously treated with tolvaptan
- Contraindicated for tolvaptan use
- Judged ineligible by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
Hallym University Kangnam Sacred Heart Hospital
Anyang-si, Gyeonggi-do, South Korea, 14068
Not Yet Recruiting
2
Seoul National University Hospital
Seoul, Republic of Korea, South Korea, 03080
Actively Recruiting
3
InjeUniversityBusanPaikHospital
Busan, South Korea, 47392
Not Yet Recruiting
4
Keimyung University Dongsan Medical Center
Daegu, South Korea, 42601
Not Yet Recruiting
5
Chonnam National University Hospital
Gwangju, South Korea, 61469
Not Yet Recruiting
6
Kangbuk Samsung Hospital
Seoul, South Korea, 03181
Not Yet Recruiting
7
Asan Medical Center
Seoul, South Korea, 05505
Not Yet Recruiting
8
Seoul National University Boramae Hospital
Seoul, South Korea, 07061
Not Yet Recruiting
9
Korea University Guro Hospital
Seoul, South Korea, 08308
Not Yet Recruiting
Research Team
J
Jisun Chun
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here